Información:
Error:
ID
34183
Descripción
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01975376
Link
https://clinicaltrials.gov/show/NCT01975376
Palabras clave
Versiones (1)
- 15/1/19 15/1/19 -
Titular de derechos de autor
see on clinicaltrials.gov
Subido en
15 de enero de 2019
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Cardiovascular Disease NCT01975376
Eligibility Cardiovascular Disease NCT01975376
- StudyEvent: Eligibility
Similar models
Eligibility Cardiovascular Disease NCT01975376
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
ID.1
Item
must be on background lipid lowering treatment.
boolean
ID.2
Item
must be at high risk of a cv event.
boolean
ID.3
Item
must have an ldl c >/=70 mg/dl (1.8 mmol/l) and < 100 mg/dl (2.6 mmol/l) or non-hdl-c >/= 100 mg/dl (2.6 mmol/l) and < 130 mg/dl (3.4 mmol/l).
boolean
ID.4
Item
an ldl c < 70 mg/dl (1.8 mmol/l) or >/= 100 mg/dl (2.6 mmol/l) or non hdl-c < 100 mg/dl (2.6 mmol/l) or >/=130 mg/dl (3.4 mmol/l).
boolean
ID.5
Item
planned coronary (pci or cabg) or other arterial revascularization.
boolean
ID.6
Item
new york heart association class iv congestive heart failure or left ventricular ejection fraction < 25% by cardiac imaging.
boolean
ID.7
Item
chronic renal insufficiency with creatinine clearance of <30 ml/min/1.73m^2 by mdrd formula or with end state renal disease on dialysis.
boolean
ID.8
Item
history of hemorrhagic stroke.
boolean
ID.9
Item
prior exposure to bococizumab or other investigational pcsk9 inhibitor.
boolean